Predicting Pancreatic Cancer Risks with New Tests
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,174 (estimated)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Other
This trial is looking for individuals who may have pancreatic problems like tumors or cysts. Participants will help gather medical information, including samples and images, to improve future diagnosis and treatment.
You may be able to join if
- I have symptoms or tests showing a possible pancreatic issue.
- I have not received treatment for my pancreas.
- I can sign the consent form willingly.
- I am willing to answer study questionnaires.
- I can donate blood or tissue samples during routine care.
You may not be able to join if
- I do not have any suspicion or diagnosis of a pancreatic issue.
- I have already received treatment for my pancreas.
- I cannot provide my consent.
- I am not willing to answer study questionnaires.
- I am not willing to donate samples or images.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityLoading trial locations…